Browse every published article, from the latest research to earlier analysis. Use the page numbers below to explore the complete archive.
An animal comparison cannot establish clinical superiority of human rescue products.
Successful intubation included several conditions beyond placing the tube.
Symptom response does not automatically identify the direction of causation.
A lower anxiety questionnaire score and deeper sedation are separate findings.
A comparison with no remimazolam is not necessarily a comparison with one standardized alternative.
Matching measured characteristics does not turn an observational comparison into a randomized trial.
A model distinguishing clinical sample groups does not automatically define an impairment threshold.
The experimental strategy included both an additional sedative and its antagonist.
A short-acting benzodiazepine can produce profound EEG suppression under some conditions.
A stable total imaging signal can conceal changes in one component of binding.
No observed adverse events in a small trial is a limited finding, not a guarantee.
Improvement during herbal treatment does not isolate a specific withdrawal intervention.
The duration threshold and sampled population determine what a long-term prescribing percentage means.
Pain relief and relief of accompanying abnormal sensations may follow different courses.
Initial awakening after an antagonist is not necessarily the final recovery state.
The percentage of time adequately sedated answers a different question from the proportion initially reaching a target.
A numerical confidence interval that does not contain its estimate should be checked before being repeated as reliable precision.
Similar observations across age groups do not establish that each ingredient of a sedation mixture is independently safe.
A treatment-completion percentage must identify whether its denominator is patients or sedation occasions.
A before-and-after improvement does not isolate one ingredient of a treatment package. A selected high-dose dependence cohort completed cognitive testing before and after an inpatient program involving slow flumazenil infusion and other treatment.
A cessation measure based on records needs its ascertainment limits explained. A nonrandomized primary-care implementation mailed educational materials through participating physicians.
Parallel behavioral and electrical recordings can add context without making a challenge perfectly specific. A case report documented marked behavioral and EEG changes after intravenous diazepam in a patient with stupor.
A statistically clear difference still requires its size and time window. A placebo-controlled trial in older patients with zoster-related pain reported modest pain-score differences on selected posttreatment days after intramuscular diazepam.
Improvement within a combination group does not by itself prove additive drug benefit. A burning-mouth study compared laser, sham treatment, clonazepam and laser plus clonazepam.
A favorable pooled sedation result does not establish the same advantage against every alternative. A review of six randomized trials examined dexmedetomidine plus midazolam across imaging, auditory testing and bronchoscopy settings.
A propofol-based group is not necessarily a benzodiazepine-free group. A retrospective pediatric study compared propofol-based sedation with a midazolam strategy.
A treatment goal should be distinguished from a diagnosis and from the patient’s own preference. A qualitative study found varied professional approaches to long-term benzodiazepine and Z-drug management.
Tolerance of one benzodiazepine does not reliably predict tolerance of every other member. A case of suspected remimazolam anaphylaxis included allergy investigation and an earlier reaction during midazolam-containing anesthesia.
A medication-use surrogate is not a direct measurement of every obstetric outcome. A small retrospective cesarean study compared remimazolam and propofol maintenance.
A successful premedication score is not a general-anesthesia endpoint. A small preschool study used sequential dose assignment and statistical modeling to estimate intranasal remimazolam doses for pre-induction sedation.